Article
Dopamine transporter trafficking and Rit2 GTPase: Mechanism of action and in vivo impact
medRxiv · 2020 · Fagan, R. R.; Kearney, P. J.; Sweeney, C. G.; Luethi, D.; Schoot Uiterkamp, F. E.; Schicker, K.; O'Connor, L. C.; Sitte, H. H.; Melikian, H. E.
Key facts
| Title | Dopamine transporter trafficking and Rit2 GTPase: Mechanism of action and in vivo impact |
|---|---|
| First author | Fagan, R. R.; Kearney, P. J.; Sweeney, C. G.; Luethi, D.; Schoot Uiterkamp, F. E.; Schicker, K.; O'Connor, L. C.; Sitte, H. H.; Melikian, H. E. |
| Journal | medRxiv |
| Published | Feb 27, 2020 |
| DOI | 10.1101/712448 |
| Devices mentioned | BK110039, DEN000008, K022086, K042152, K103302, K940422, K982100 |
| Product codes mentioned | CFN, DFZ, NDS, PCA, JCI, KIT, NJT, OOI |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1